FDA Approved: DESCOVY — Supplemental Application (Gilead Sciences, Inc.)

View source ↗

Summary

FDA approved a supplemental application for DESCOVY (emtricitabine and tenofovir alafenamide) from Gilead Sciences, updating the drug's labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Descovy (emtricitabine/tenofovir alafenamide)

Snippet

SUPPL AP for DESCOVY (EMTRICITABINE AND TENOFOVIR ALAFENAMIDE)